Clinical Study
Outcome of Endometrial Cancer Stage IIIA with Adnexa or Serosal Involvement Only
Table 1
Tumor and treatment characteristics of 67 patients with endometrial carcinoma stage IIIA according to adnexa or serosa involvement.
| | Characteristics | Adnexa | Serosa | value | | (%) | (%) |
| | Age | | | | | <60 years | 21 (45.7) | 4 (19.1) | | | ≥60 years | 25 (54.3) | 17 (80.9) | .037 | | Differentiation grade | | | | | Grade 1 | 23 (50) | 7 (33.3) | | | Grade 2 | 11 (23.9) | 8 (38.1) | Ns | | Grade 3 | 12 (26.1) | 6 (28.6) | | | Lymph vascular space involvement | | | | | yes | 19 (41.3) | 9 (42.9) | | | none | 27 (58.7) | 12 (57.1) | Ns | | Myometrium infiltration | | | | | <1/2 | 21 (43.5) | 0 (0) | | | >1/2 | 26 (56.5) | 20 (100) | | | Cervical involvement | | | | | none | 29 (63) | 13 (61.9) | | | endocervical glands | 2 (4.4) | 1 (4.8) | Ns | | stroma | 15 (32.6) | 7 (33.3) | | | Peritoneal washing | | | | | Positive | 7 (15.2) | 1 (4.8) | | | Negative | 15 (32.6) | 8 (38.1) | Ns | | Unknown | 24 (52.2) | 12 (57.1) | | | Type of radiotherapy | | | | | Pelvic | 26 (56.5) | 18 (85.7) | | | Pelvic + brachytherapy | 13 (28.3) | 2 (9.5) | Ns | | Pelvic + external boost | 4 (8.7) | 1 (4.8) | | | Abdomen/pelvic | 1 (2.2) | 0 | | | Abd/pelvic + brachy | 2 (4.4) | 0 | | | External dose (no boost) | | | | | 30.0 Gy | 1 (2.2) | 0 | | | 36–45.0 Gy | 11 (23.9) | 2 (9.5) | Ns | | 46.0 Gy | 34 (73.9) | 19 (90.5) | |
|
|
